Colour theme
Theme
Sign in
Insider · CIK 0001677513

Broadrick Dale

CIK 0001677513 Name as filed on the most recent filing

Filed as Broadrick Dale (33)

110 transaction lines · from 33 filings · filed 2019-05-09 to 2024-11-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

110 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2024-10-28 BioRestorative Therapies, Inc.
BRTX
S, Open-market sale 1,112 disposed 1.58 1,756.96 Form 4, filing 0001021771-24-000184
2024-02-09 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 86,041 acquired 1.32 113,574.12 Form 4, filing 0001021771-24-000038
2024-02-08 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 73,959 acquired 1.25 92,448.75 Form 4, filing 0001021771-24-000038
2024-02-08 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 83,626 acquired 1.34 112,058.84 Form 4, filing 0001021771-24-000035
2024-02-07 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 36,374 acquired 1.38 50,196.12 Form 4, filing 0001021771-24-000035
2023-12-01 BioRestorative Therapies, Inc.
BRTX
S, Open-market sale 250 disposed 1.88 469.25 Form 4, filing 0001021771-23-000118
2023-11-27 BioRestorative Therapies, Inc.
BRTX
S, Open-market sale 278 disposed 1.89 525.42 Form 4, filing 0001021771-23-000116
2023-09-15 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 10,000 acquired 1.66 16,600.00 Form 4, filing 0001021771-23-000098
2023-09-14 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 10,000 acquired 1.54 15,400.00 Form 4, filing 0001021771-23-000098
2023-09-07 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 1,000 acquired 1.91 1,910.00 Form 4, filing 0001021771-23-000092
2023-09-07 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 1,000 acquired 1.81 1,810.00 Form 4, filing 0001021771-23-000092
2023-07-28 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 500 acquired 2.89 1,445.00 Form 4, filing 0001021771-23-000092
2023-07-27 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 1,000 acquired 2.80 2,800.00 Form 4, filing 0001140361-23-036665
2023-02-22 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 5,000 acquired 2.84 14,200.00 Form 4, filing 0001567619-23-004348
2023-02-22 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 1,000 acquired 2.95 2,950.00 Form 4, filing 0001567619-23-004348
2022-11-30 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 100 acquired 2.78 278.00 Form 4, filing 0001567619-23-004348
2022-11-30 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 100 acquired 2.77 277.00 Form 4, filing 0001567619-23-004348
2022-09-23 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 300 acquired 2.83 848.97 Form 4, filing 0001567619-22-017856
2022-07-13 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 200 acquired 3.00 600.00 Form 4, filing 0001567619-22-014051
2022-07-12 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 900 acquired 2.97 2,673.00 Form 4, filing 0001567619-22-014051
2022-07-06 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 100 acquired 3.38 337.99 Form 4, filing 0001567619-22-014051
2022-06-30 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 1,900 acquired 3.08 5,849.91 Form 4, filing 0001567619-22-013688
2022-06-21 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 100 acquired 3.68 367.96 Form 4, filing 0001567619-22-013309
2022-06-17 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 600 acquired 3.80 2,281.98 Form 4, filing 0001567619-22-013309
2022-06-16 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 2,000 acquired 3.81 7,611.00 Form 4, filing 0001567619-22-013111
2022-06-15 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 1,200 acquired 3.72 4,463.88 Form 4, filing 0001567619-22-013111
2022-06-13 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 1,300 acquired 3.92 5,096.52 Form 4, filing 0001567619-22-012901
2022-06-10 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 600 acquired 4.23 2,539.98 Form 4, filing 0001567619-22-012747
2022-06-09 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 1,000 acquired 4.27 4,265.70 Form 4, filing 0001567619-22-012747
2022-06-08 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 2,400 acquired 4.33 10,395.12 Form 4, filing 0001567619-22-012605
2022-06-07 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 3,600 acquired 4.72 17,003.16 Form 4, filing 0001567619-22-012605
2022-06-06 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 3,000 acquired 4.93 14,797.50 Form 4, filing 0001567619-22-012430
2022-06-03 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 1,200 acquired 4.90 5,879.28 Form 4, filing 0001567619-22-012430
2022-06-02 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 1,000 acquired 4.69 4,687.80 Form 4, filing 0001567619-22-012367
2022-06-01 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 9,213 acquired 4.46 41,122.23 Form 4, filing 0001567619-22-012250
2022-05-27 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 10,957 acquired 3.61 39,592.02 Form 4, filing 0001567619-22-012010
2022-05-26 BioRestorative Therapies, Inc.
BRTX
S, Open-market sale 2,000 disposed 3.44 6,875.60 Form 4, filing 0001567619-22-011949
2022-05-26 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 4,950 acquired 3.51 17,364.10 Form 4, filing 0001567619-22-011949
2022-04-06 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 2,500 acquired 5.66 14,150.00 Form 4, filing 0001567619-22-008301
2022-04-05 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 30,000 acquired 5.64 169,200.00 Form 4, filing 0001567619-22-008245
2022-04-05 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 16,000 acquired 5.84 93,440.00 Form 4, filing 0001567619-22-008245
2022-03-31 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 10,000 acquired 4.71 47,100.00 Form 4, filing 0001567619-22-007864
2022-03-31 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 700 acquired 4.84 3,388.00 Form 4, filing 0001567619-22-007864
2022-03-29 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 5,000 acquired 5.12 25,600.00 Form 4, filing 0001567619-22-007864
2022-03-21 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 10,000 acquired 4.35 43,500.00 Form 4, filing 0001567619-22-007664
2022-03-09 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 11,875 acquired 4.00 47,500.00 Form 4, filing 0001567619-22-007664
2022-03-08 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 8,125 acquired 4.00 32,500.00 Form 4, filing 0001567619-22-007664
2022-03-07 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 24,392 acquired 4.43 108,056.56 Form 4, filing 0001567619-22-007664
2022-03-04 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 3,800 acquired 5.51 20,938.00 Form 4, filing 0001567619-22-007664
2022-03-03 BioRestorative Therapies, Inc.
BRTX
P, Open-market purchase 47,648 acquired 5.47 260,634.56 Form 4, filing 0001567619-22-007664

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 106
  • Open-market sale 4
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Broadrick Dale, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001677513

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.